Endometrial Cancer Research Articles

Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as a firstline treatment for endometrial cancer: Overall survival and additional secondary efficacy en‑dpoints by mismatch repair status in the DUO-E/GOG-3041/ENGOT-EN10 Trial

Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as a firstline treatment for endometrial cancer: Overall survival and additional secondary efficacy en‑dpoints by mismatch repair status in the DUO-E/GOG-3041/ENGOT-EN10 Trial

Sentinel lymph node size alone should not preclude sentinel lymph node biopsy for endometrial cancer patients undergoing surgical staging

Sentinel lymph node size alone should not preclude sentinel lymph node biopsy for endometrial cancer patients undergoing surgical staging

Dosimetry, toxicity, and outcomes of medically inoperable endometrial cancer patients treated with Y-tandem brachytherapy

Dosimetry, toxicity, and outcomes of medically inoperable endometrial cancer patients treated with Y-tandem brachytherapy

Conservative, non-surgical treatment for young patients with early-stage, low-grade endometrial cancer: Population-level trends and oncologic outcomes

Conservative, non-surgical treatment for young patients with early-stage, low-grade endometrial cancer: Population-level trends and oncologic outcomes

Spatial transcriptomics identifies unique loss of immunosurveillance in endometrial cancers of women with severe obesity

Spatial transcriptomics identifies unique loss of immunosurveillance in endometrial cancers of women with severe obesity

Serum CA-125 levels in the context of ProMisE molecular classification provide preoperative prognostic information that can direct endometrial cancer management

Serum CA-125 levels in the context of ProMisE molecular classification provide preoperative prognostic information that can direct endometrial cancer management

Duration of bleeding prior to endometrial cancer diagnosis: An opportunity to rethink our approach to detection and diagnosis in at-risk groups

Duration of bleeding prior to endometrial cancer diagnosis: An opportunity to rethink our approach to detection and diagnosis in at-risk groups

Nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study

nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study

Disease-free survival as a predictor of overall survival in patients with high-risk endometrial cancer receiving adjuvant therapy

Disease-free survival as a predictor of overall survival in patients with high-risk endometrial cancer receiving adjuvant therapy

HER2 status, MMR, and p53 expression among endometrial cancer patients

HER2 status, MMR, and p53 expression among endometrial cancer patients

The role of pelvic washings in patients with endometrial cancer of high-risk histology in a single institution: A retrospective review

The role of pelvic washings in patients with endometrial cancer of high-risk histology in a single institution: A retrospective review

Are uterine fibroids associated with delay in diagnosis of endometrial cancer?

Are uterine fibroids associated with delay in diagnosis of endometrial cancer?

Diagnostic and prognostic accuracy of exosomal miRNA-based signature for endometrial cancer

Diagnostic and prognostic accuracy of exosomal miRNA-based signature for endometrial cancer

Cervicovaginal metabolome is predictive of endometrial cancer and tumor characteristics and leveraged for risk stratification

Cervicovaginal metabolome is predictive of endometrial cancer and tumor characteristics and leveraged for risk stratification

Cervicovaginal metabolome is predictive of endometrial cancer and tumor characteristics and leveraged for risk stratification

Cervicovaginal metabolome is predictive of endometrial cancer and tumor characteristics and leveraged for risk stratification

Uterine manipulation during minimally invasive surgery for early-stage endometrial cancer (MAN-U trial)

Uterine manipulation during minimally invasive surgery for early-stage endometrial cancer (MAN-U trial)

Preoperative diagnosis of endometrial intraepithelial neoplasia and risk of concurrent endometrial cancer: Does tissue sampling technique matter?

Preoperative diagnosis of endometrial intraepithelial neoplasia and risk of concurrent endometrial cancer: Does tissue sampling technique matter?

Overall survival among patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial

Overall survival among patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial

Survival analysis of a prospective intraoperative algorithm to guide surgical staging in early-stage endometrial cancer

Survival analysis of a prospective intraoperative algorithm to guide surgical staging in early-stage endometrial cancer

Patterns of adjuvant therapy for endometrial cancer with sentinel lymph node biopsy

Patterns of adjuvant therapy for endometrial cancer with sentinel lymph node biopsy